Targeting CD137 enhances the efficacy of cetuximab
Holbrook E. Kohrt(Stanford University), Ronald Levy(Hôpital Necker-Enfants Malades)
Cited by 161
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling
|Blood|2016|80
Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors
|The Journal of Immunology|2023|3